Medivir/Tibotec HCV collaboration <A HREF="http://www.medivir.se/v3/en/ir_media/press_releases.aspx?id=121" target="_blank">http://www.medivir.se/v3/en/ir_media/press_releases.aspx?id=121</A> Although early, MVIRs protease inhibitor looks promising. FWIW, the CEO publicly stated in April that their drug looks better than Telaprevir..